THE FAVORABLE HEMODYNAMIC RESPONSE TO CARVEDILOL IN HEART FAILURE PATIENTS MIGHT BE COMPROMISED BY TWO ADRENERGIC RECEPTOR POLYMORPHISMS.

被引:0
|
作者
Zakrzewski-Jakubiak, M. [1 ]
de Denus, S. [1 ]
Leblanc, M. [2 ]
White, M. [2 ]
Turgeon, J. [1 ]
机构
[1] Univ Montreal, Montreal, PQ, Canada
[2] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S2 / S3
页数:2
相关论文
共 50 条
  • [31] Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients
    Berends, Annika M. A.
    Bolhuis, Mathieu S.
    Nolte, Ilja M.
    Buitenwerf, Edward
    Links, Thera P.
    Timmers, Henri J. L. M.
    Feelders, Richard A.
    Eekhoff, Elisabeth M. W.
    Corssmit, Eleonora P. M.
    Bisschop, Peter H.
    Haak, Harm R.
    van Schaik, Ron H. N.
    El Bouazzaoui, Samira
    Wilffert, Bob
    Kerstens, Michiel N.
    BIOMEDICINES, 2022, 10 (04)
  • [32] β-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography
    Aquilante, C. L.
    Yarandi, H. N.
    Cavallari, L. H.
    Andrisin, T. E.
    Terra, S. G.
    Lewis, J. F.
    Hamilton, K. H.
    Johnson, J. A.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (06): : 408 - 415
  • [33] β-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography
    C L Aquilante
    H N Yarandi
    L H Cavallari
    T E Andrisin
    S G Terra
    J F Lewis
    K K Hamilton
    J A Johnson
    The Pharmacogenomics Journal, 2008, 8 : 408 - 415
  • [34] β1 and β2-adrenergic receptor gene polymorphisms are not associated with heart failure
    Lavandero, S
    Moraga, F
    Mellado, R
    Chiong, M
    Diaz-Araya, G
    Castro, P
    Greig, D
    Perez, O
    Moreno, M
    FASEB JOURNAL, 2003, 17 (04): : A652 - A652
  • [35] Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure
    Wagoner, LE
    Craft, LL
    Zengel, P
    McGuire, N
    Rathz, DA
    Dorn, GW
    Liggett, SB
    AMERICAN HEART JOURNAL, 2002, 144 (05) : 840 - 846
  • [36] β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
    Liu, Wen-Nan
    Fu, Kai-Li
    Gao, Hai-Yang
    Shang, Yuan-Yuan
    Wang, Zhi-Hao
    Jiang, Gui-Hua
    Zhang, Yun
    Zhang, Wei
    Zhong, Ming
    PLOS ONE, 2012, 7 (07):
  • [37] β-Adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure
    Kaye, DM
    Smirk, B
    Williams, C
    Jennings, G
    Esler, M
    Holst, D
    PHARMACOGENETICS, 2003, 13 (07): : 379 - 382
  • [38] Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET
    Cleland J.G.F.
    Current Heart Failure Reports, 2004, 1 (2) : 82 - 88
  • [39] Heart failure etiology and hemodynamic response to nicorandil in patients with acute heart failure syndromes
    Hattori, H.
    Minami, Y.
    Yamaguchi, J.
    Kajimoto, K.
    Hoshi, H.
    Kojika, A.
    Arashi, H.
    Mori, F.
    Shiga, T.
    Hagiwara, N.
    EUROPEAN HEART JOURNAL, 2010, 31 : 855 - 855
  • [40] Polymorphisms of the beta(2) adrenergic receptor (beta(2)AR) affect exercise capacity in patients with heart failure
    Wagoner, LE
    Hoit, BD
    Hedger, VH
    Donnelly, E
    Bhat, G
    Walsh, RA
    Liggett, SB
    CIRCULATION, 1996, 94 (08) : 3926 - 3926